Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Director | Options to Purchase Common Stock | 25K | Aug 15, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Aug 15, 2025 | 1 | $0 | 4 | Aug 18, 2025 | Director |
ENTO | Entero Therapeutics, Inc. | Aug 11, 2025 | 0 | $0 | 3 | Aug 18, 2025 | Director |
LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | Jul 18, 2025 | 0 | $0 | 3 | Jul 21, 2025 | Director |